All SEC Filings :: Avalo Therapeutics, Inc. (AVTX)

Filing Type:

Year:

Date	Form	Description	Pages
12/20/19	S-4	Registration of securities issued in business combination transactions Documents EX-23.1 EX-23.2 EX-99.3 EX-99.5 EX-99.6	540
12/11/19	4	Statement of changes in beneficial ownership of securities	2
12/11/19	4	Statement of changes in beneficial ownership of securities	2
12/11/19	4	Statement of changes in beneficial ownership of securities	2
12/11/19	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Documents EX-2.1	69
12/11/19	8-K/A	Current report filing Documents EX-2.1	69
12/09/19	8-K	Current report filing Documents EX-99.1	17
12/06/19	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities	10
12/05/19	8-K	Current report filing Documents EX-2.1 EX-10.1 EX-10.2 EX-10.3 EX-10.4 EX-10.5 EX-99.1	134
12/05/19	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Documents EX-2.1 EX-10.1 EX-10.2 EX-10.3 EX-10.4 EX-10.5 EX-99.1	134